Vinflunine (VFL) in combination with carboplatin (CBDCA) for treatment of advanced non-small cell lung cancer (NSCLC) in chemonaive patients (pts): Phase I and pharmacokinetic study

被引：1
|
作者：
Robinet, G
Afenjar, K
Gouva, S
Planchard, D
Zorza, G
Tourani, J
机构：
[1] Hop Morvan, Brest, France
[2] Inst Rech Pierre Fabre, Boulogne, France
[3] CHU La Miletrie, Poitiers, France
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81059-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [41] Vinorelbine, carboplatin and gemcitabine (VGC) in the treatment of untreated advanced/metastatic non-small cell lung cancer (NSCLC): A phase I study
    Piantedosi, FV
    Pontillo, V
    Brancaccio, L
    Crispino, C
    Biscione, GL
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S255 - S255
  • [42] Vinorelbine oral (NVBO) and carboplatin (CBDCA) in chemonaive advanced non-small cell lung cancer (NSCLC): Proven efficacy of 4 cycles followed by maintenance oral chemotherapy
    Reck, Martin
    Macha, Hans-Nikol
    Del Barco, Sonia
    Cornes, Paul
    Pouget, Jean-Christophe
    Abratt, Raymond
    ANNALS OF ONCOLOGY, 2006, 17 : 226 - 226
  • [43] Carboplatin (CBDCA), S-1 and concurrent thoracic radiotherapy (TRT) for elderly patients with locally advanced non-small cell lung cancer (NSCLC): A phase I study.
    Niho, Seiji
    Yoh, Kiyotaka
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Ohmatsu, Hironobu
    Goto, Koichi
    Hosomi, Yukio
    Tanaka, Hiroshi
    Okamoto, Hiroaki
    Nihei, Keiji
    Akimoto, Tetsuo
    Ohe, Yuichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Ono, Yasushi
    Hino, Mitsunori
    Ueda, Yuka
    Kamizuru, Ryoko
    Omata, Masatoshi
    Uehara, Takashi
    Tanaka, Yosuke
    Soma, Tomoyuki
    Kudoh, Shoji
    MEDICAL ONCOLOGY, 2007, 24 (04) : 402 - 406
  • [45] Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Yasushi Ono
    Mitsunori Hino
    Yuka Ueda
    Ryoko Kamizuru
    Masatoshi Omata
    Takashi Uehara
    Yosuke Tanaka
    Tomoyuki Soma
    Shoji Kudoh
    Medical Oncology, 2007, 24 : 402 - 406
  • [46] A phase I, pharmacokinetic (PK), and biological study of FGF inhibition modulating paclitaxel/carboplatin (P/C) chemotherapy in non-small cell lung cancer (NSCLC) patients (pts).
    Villalona-Calero, MA
    Otterson, GA
    Kanter, S
    Young, D
    Fischer, B
    Straiko, M
    Chen, D
    Brooks, R
    Song, S
    Zhang, Y
    Yeh, T
    Chan, K
    Grever, M
    Wientjes, G
    Au, JL
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3738S - 3738S
  • [47] Carboplatin-vinorelbine (CBDCA-VNB): An effective and well-tolerated first-line treatment in advanced non-small cell lung cancer (NSCLC) patients (PTS)
    Cremonesi, M
    Cazzaniga, M
    Ciotti, R
    Barni, S
    ANNALS OF ONCOLOGY, 2000, 11 : 3 - 3
  • [48] A phase I study of binimetinib, a MEK inhibitor, in combination with pembrolizumab in patients with advanced non-small cell lung cancer (NSCLC)
    Theriau, Christopher F.
    Feng, Jamie
    Eng, Lawson
    Shepherd, Frances A.
    DeCarolis, Mary
    Glenns, Vivian
    Kulkarni, Swati
    VanderMeer, Rachel
    Zurawska-Fortin, Urszula
    Hao, Desiree
    Le, Lisa
    Wozniczka, Isabel
    Al-Kindy, Aida
    Xie, Danny
    Zhang, Tong
    Subramanian, Vasanth
    Stockley, Tracy
    Bradbury, Penelope A.
    Liu, Geoffrey
    Leighl, Natasha B.
    CANCER RESEARCH, 2023, 83 (08)
  • [49] Phase II study of bevacizumab in combination with docetaxel and carboplatin in patients with metastatic non-small cell lung cancer (NSCLC)
    William, W. N., Jr.
    Kies, M. S.
    Fossella, F. V.
    Gladish, G.
    Heymach, J. V.
    Glisson, B. S.
    Tse, W. H.
    Liu, D.
    Herbst, R. S.
    Lippman, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] A phase II and pharmacogenomic study of Irinotecan and carboplatin in advanced non-small cell lung cancer (NSCLC).
    Pillot, GA
    Hennenfent, K
    Read, W
    Marsh, S
    McLeod, HL
    Gao, F
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
12345